[HTML][HTML] Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based …

J Mariën, A Ceulemans, J Michiels, L Heyndrickx… - Journal of virological …, 2021 - Elsevier
Large-scale serosurveillance of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)
will only be possible if serological tests are sufficiently reliable, rapid and …

Persistence of IgG response to SARS-CoV-2

…, K Dierick, N Fischer, L Heyndrickx… - The Lancet Infectious …, 2021 - thelancet.com
Little is known about the duration and protective capacity of the humoral immune response
to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In studies from Iceland1 …

[HTML][HTML] Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients

…, J Neumann, P Pannus, L Heyndrickx… - Journal of hematology & …, 2021 - Springer
Background Factors affecting response to SARS-CoV-2 mRNA vaccine in allogeneic
hematopoietic stem cell transplantation (allo-HCT) recipients remain to be elucidated. Methods …

Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin

…, W Janssens, J Mascola, L Heyndrickx… - Journal of …, 1995 - Am Soc Microbiol
The genetic diversity of the envelope glycoprotein of human immunodeficiency virus type 1 (HIV-1)
isolates was studied. HIV-1 isolates were obtained from eight countries in Africa: …

Simplified Strategy for Detection of Recombinant Human Immunodeficiency Virus Type 1 Group M Isolates bygag/env Heteroduplex Mobility Assay

L Heyndrickx, W Janssens, L Zekeng… - Journal of …, 2000 - Am Soc Microbiol
We developed a heteroduplex mobility assay in the gaggene (gag HMA) for the identification
of group M subtypes A to H. The assay covers the region coding for amino acid 132 of p24 …

[HTML][HTML] International network for comparison of HIV neutralization assays: the NeutNet report

…, P Lusso, S Zolla-Pazner, H Donners, L Heyndrickx… - PloS one, 2009 - journals.plos.org
Background Neutralizing antibody assessments play a central role in human immunodeficiency
virus type-1 (HIV-1) vaccine development but it is unclear which assay, or combination of …

[HTML][HTML] Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant

KK Ariën, L Heyndrickx, J Michiels, K Vereecken… - npj Vaccines, 2022 - nature.com
We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants
in unimmunized infected (group 1), immunised and boosted (group 2) and infected …

[HTML][HTML] A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants …

…, N François, S Valembois, L Heyndrickx… - Molecular Therapy, 2022 - cell.com
Self-amplifying RNA vaccines may induce equivalent or more potent immune responses at
lower doses compared to non-replicating mRNA vaccines via amplified antigen expression. …

[HTML][HTML] Alternative sampling specimens for the molecular detection of mpox (formerly monkeypox) virus

…, M Mangelschots, S Coppens, L Heyndrickx… - Journal of Clinical …, 2023 - Elsevier
Background Mpox (formerly monkeypox) is a viral disease caused by the mpox virus (MPXV),
endemic in Central and West Africa and currently causing a global outbreak of …

[PDF][PDF] Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients

…, S Humblet-Baron, P Pannus, L Heyndrickx… - Cancer Cell, 2022 - cell.com
Allogeneic hematopoietic stem cell transplant (allo-HCT) recipients are particularly at risk of
severe COVID-19. In addition, they have lower serological response to two doses of mRNA …